Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy

Several studies have suggested the possibility of a prognostic relationship between Epstein–Barr virus (EBV) and diffuse large B‐cell lymphoma (DLBCL). The clinical outcome of EBV‐associated DLBCL is not clear, especially since the introduction of rituximab. We retrospectively analyzed 222 elderly p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2013-09, Vol.88 (9), p.774-779
Hauptverfasser:	Ahn, Jae‐Sook, Yang, Deok‐Hwan, Duk Choi, Yoo, Jung, Sung‐Hoon, Yhim, Ho‐Young, Kwak, Jae‐Yong, Sung Park, Ho, Shin, Myung‐Geun, Kim, Yeo‐Kyeoung, Kim, Hyeoung‐Joon, Lee, Je‐Jung
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy Cyclophosphamide - therapeutic use DNA, Viral - isolation & purification Doxorubicin - therapeutic use Female Hematology Herpesvirus 4, Human - growth & development Humans Lymphoma Lymphoma, B-Cell - drug therapy Lymphoma, B-Cell - mortality Lymphoma, B-Cell - virology Male Medical research Middle Aged Neoplasm Staging Prednisone - therapeutic use Retrospective Studies Survival Analysis Treatment Outcome Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!